The strict rules applied in Italy during the recent COVID-19 pandemic, with the prohibition to attend any regular outdoor activity, are likely to influence the degree of metabolic control of patients with type 2 diabetes. The aim of this observational, prospective, single centre study was to evaluate the immediate impact of the lockdown rules on the metabolic profile of a cohort of patients with type 2 diabetes.
All the patients with type 2 diabetes who were previously scheduled for a follow-up visit in our outpatient diabetes clinic during the lockdown for COVID-19 (March 9, 2020-May 04, 2020) were contacted by phone. Patients who accepted to take part of the study received a medical prescription for routine analysis via email. They were asked to perform blood drawing one week after the end of the lockdown period and transmitted us the results. We then compared the metabolic profile tested one week after the end of the lockdown with the last value and the mean of the last three determinations performed before the pandemic emergency.
Study Type
OBSERVATIONAL
Enrollment
114
Every kind of antidiabetic treatment, oral or injective, were considered including patients treated only with diet
University of Pisa
Pisa, Italy
Glucose
Blood glucose was expressed in mg/dl and was determined by standard techniques.
Time frame: One week after the end of the lockdown period
HbA1c
HbA1c was expressed as percentage or mmol/l and was determined by standard techniques.
Time frame: One week after the end of the lockdown period
Lipid profile
Complete lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, Triglcerydes) were expressed in mg/dl or mmol/l and were determined by standard techniques.
Time frame: One week after the end of the lockdown period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.